<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Reynolds JA</submitter><funding>Versus Arthritis</funding><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><funding>Wellcome Trust</funding><funding>Biotechnology and Biological Sciences Research Council</funding><pagination>22341</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4772382</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6</volume><pubmed_abstract>Patients with systemic lupus erythematosus (SLE) have accelerated cardiovascular disease and dysfunctional endothelial repair mechanisms. Myeloid angiogenic cells (MACs), derived from circulating monocytes, augment vascular repair by paracrine secretion of pro-angiogenic factors. We observed that SLE MACs are dysfunctional and secrete pro-inflammatory cytokines. We also found that the vitamin D receptor was transiently expressed during MAC differentiation and that in vitro, calcitriol increased differentiation of monocytes into MACs in both SLE and in a model using the prototypic SLE cytokine, interferon-alpha. The active form of vitamin D (calcitriol) restored the SLE MAC phenotype towards that of healthy subjects with reduced IL-6 secretion, and normalised surface marker expression. Calc</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Vitamin D improves endothelial dysfunction and restores myeloid angiogenic cell function via reduced CXCL-10 expression in systemic lupus erythematosus.</pubmed_title><pmcid>PMC4772382</pmcid><funding_grant_id>MR/M008908/1</funding_grant_id><funding_grant_id>NF-SI-0512-10105</funding_grant_id><funding_grant_id>20380</funding_grant_id><funding_grant_id>MR/L010240/1</funding_grant_id><funding_grant_id>MANMKBRU-2012-1</funding_grant_id><funding_grant_id>MR/L00254X/1</funding_grant_id><funding_grant_id>G1000417/94909</funding_grant_id><pubmed_authors>Ray DW</pubmed_authors><pubmed_authors>Bruce IN</pubmed_authors><pubmed_authors>Reynolds JA</pubmed_authors><pubmed_authors>Williamson K</pubmed_authors><pubmed_authors>Alexander MY</pubmed_authors><pubmed_authors>Haque S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Vitamin D improves endothelial dysfunction and restores myeloid angiogenic cell function via reduced CXCL-10 expression in systemic lupus erythematosus.</name><description>Patients with systemic lupus erythematosus (SLE) have accelerated cardiovascular disease and dysfunctional endothelial repair mechanisms. Myeloid angiogenic cells (MACs), derived from circulating monocytes, augment vascular repair by paracrine secretion of pro-angiogenic factors. We observed that SLE MACs are dysfunctional and secrete pro-inflammatory cytokines. We also found that the vitamin D receptor was transiently expressed during MAC differentiation and that in vitro, calcitriol increased differentiation of monocytes into MACs in both SLE and in a model using the prototypic SLE cytokine, interferon-alpha. The active form of vitamin D (calcitriol) restored the SLE MAC phenotype towards that of healthy subjects with reduced IL-6 secretion, and normalised surface marker expression. Calc</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Mar</publication><modification>2025-05-29T21:40:21.163Z</modification><creation>2025-05-29T21:40:21.163Z</creation></dates><accession>S-EPMC4772382</accession><cross_references><pubmed>26930567</pubmed><doi>10.1038/srep22341</doi></cross_references></HashMap>